Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,993 | 154,083 | 133,019 | 105,396 | 114,615 |
| Marketable Securities | 362,320 | 428,830 | 273,376 | 326,871 | 328,546 |
| Receivables | 19,312 | 11,237 | 3,507 | 9,582 | 6,073 |
| Inventories | 4,664 | 366 | N/A | N/A | N/A |
| TOTAL | $548,751 | $603,057 | $414,809 | $446,056 | $453,899 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 2 | 5 |
| Investments And Advances | 89,938 | 119,520 | 10,029 | 29,516 | 87,416 |
| Other Non-Current Assets | 2,018 | 2,239 | 973 | 1,373 | 1,708 |
| TOTAL | $91,956 | $121,759 | $11,002 | $30,891 | $89,129 |
| Total Assets | $640,707 | $724,816 | $425,811 | $476,947 | $543,028 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,149 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 24,037 | 42,973 | 10,404 | 14,670 | 16,356 |
| Accrued Expenses | 55,981 | 60,096 | 48,121 | 26,809 | 33,395 |
| TOTAL | $94,551 | $103,549 | $59,377 | $42,472 | $50,805 |
| Non-Current Liabilities | |||||
| Long Term Debt | 329,644 | 331,565 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,453 | 1,578 | 0 | 133 | 327 |
| TOTAL | $331,097 | $333,143 | $2 | $137 | $334 |
| Total Liabilities | $425,648 | $436,692 | $59,379 | $42,609 | $51,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,047 | 86,024 | 85,358 | 85,096 | 84,987 |
| Common Shares | 9 | 9 | 9 | 9 | 8 |
| Retained earnings | -1,306,004 | -1,221,158 | -1,126,989 | -1,042,863 | -974,800 |
| Other shareholders' equity | 527 | 163 | 371 | -817 | -756 |
| TOTAL | $215,059 | $288,124 | $366,432 | $434,338 | $491,889 |
| Total Liabilities And Equity | $640,707 | $724,816 | $425,811 | $476,947 | $543,028 |